Obésité : ce qui a changé en 2025
Abstract
Obesity and overweight cause 1.6 million premature deaths annually, yet only 7% of countries have health systems prepared to address this global crisis, with an estimated economic impact of $3 trillion per year. A shift in care delivery is emerging, moving beyond physical stereotypes and redefining obesity in terms of diagnosis, pathophysiology, and complications. Pharmacological treatment is undergoing a major evolution, driven by incretin-based therapies and supported by over 1,000 ongoing clinical trials, with two-thirds in phases II and III. This article highlights this year's major advances, emerging treatments, and future therapeutic prospects.
Fields of Study & Subjects
Pharmacology and Obesity Treatment
Bariatric Surgery and Outcomes
Obesity
Physical Activity
Diet
Publication details
- Journal / source
- JMIG
- Volume
- 22
- Issue
- 945
- Pages
- 53–57
- Publication date
- 1 January 2026
- Language
- EN